<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xml:lang="en">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>Intention-to-treat concept: A review</title>
        <author>SandeepK Gupta</author>
      </titleStmt>
      <publicationStmt>
        <p>Tag layer of the DHSS Meta-Tagging Project. The article text is reproduced from the
           staged copy named in sourceDesc and is not altered; the tags are held separately in
           standOff so that overlapping and nested spans are preserved.</p>
      </publicationStmt>
      <sourceDesc>
        <bibl>
          <title>Intention-to-treat concept: A review</title>
          <date>2011</date>
          <publisher>Perspectives in Clinical Research</publisher>
          <idno type="DOI">10.4103/2229-3485.83221</idno>
          
          <idno type="record">gupta2011-intention-treat-concept-review</idno>
          <note type="staged-file">gupta2011-intention-treat-concept-review.txt, the project's staged copy</note>
          <note type="text-sha1">75266a5f8b29470b0f6a7b34e62508ff4098401c</note>
          <note type="rights">cc-by-nc-sa</note>
        </bibl>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <textClass><keywords><term>statistics</term></keywords></textClass>
      <particDesc>
        <person xml:id="paper"><p>the paper's own words</p></person>
        <person xml:id="tagger"><p>the tag layer; a sentence written by the tagger about the
          paper, always anchored to a quotation but not itself a quotation</p></person>
      </particDesc>
    </profileDesc>
    <revisionDesc>
      <change when="2026-10-06"
              who="build_paper_edition.py">0 spans located by searching the stored text for the quote's exact words, allowing any whitespace between them</change>
    </revisionDesc>
  </teiHeader>
  <standOff>
    <spanGrp type="tags">
      <span xml:id="t0" type="object_of_study" ana="#object_of_study" resp="#paper">
        <label>the analysis population of a randomised trial - which subjects are counted when compliance and follow-up fail - and the several incompatible definitions the regulators and the literature give it</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t1" type="research_question" ana="#research_question" resp="#paper">
        <label>what the intention-to-treat principle is, what it buys, what it costs, and where the guidelines disagree about applying it</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t2" type="contribution" ana="#contribution" resp="#paper">
        <label>assembles the definitions of ITT, per-protocol, modified ITT and the full analysis set side by side with the regulator that issues each, and reports that the modified variant has no consistent definition at all</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t3" type="claim_type" ana="#claim_type" resp="#paper">
        <label>critique</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t4" type="phenomenon" ana="#phenomenon" resp="#paper">
        <label>one analysis population with four names in circulation, each attached to a different regulator, and a modified variant defined case by case</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t5" type="method" ana="#method" resp="#paper">
        <label>review</label>
        <term>review</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t6" type="mechanisms" ana="#mechanisms[0]" resp="#tagger" cert="0.95">
        <label>THE DEFINITION IS A TRIPLE REFUSAL TO CONDITION ON ANYTHING THAT HAPPENED AFTER RANDOMISATION - `regardless of their adherence with the entry criteria, regardless of the treatment they actually received, and regardless of subsequent withdrawal from treatment or deviation from the protocol`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t7" type="mechanisms" ana="#mechanisms[1]" resp="#tagger" cert="0.95">
        <label>and the reason is that the alternative destroys what randomisation bought: `If noncompliant subjects and dropouts are excluded from the final analysis, it might create important prognostic differences among treatment groups` - and subjects `may be noncompliant or may drop out due to their response of treatment`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t8" type="mechanisms" ana="#mechanisms[2]" resp="#tagger" cert="0.95">
        <label>THE COST IS PAID IN THE SAME COIN. `In ITT analysis, estimate of treatment effect is generally CONSERVATIVE because of DILUTION due to noncompliance` - the property that makes it unbiased is the property that makes it small</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t9" type="mechanisms" ana="#mechanisms[3]" resp="#tagger" cert="0.95">
        <label>so the criticism is symmetrical: ITT `has been criticized for being too cautious and thus being more susceptible to type II error`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t10" type="mechanisms" ana="#mechanisms[4]" resp="#tagger" cert="0.95">
        <label>AND THE TWO POPULATIONS FAIL IN OPPOSITE DIRECTIONS, WHICH IS WHY THE CHOICE IS NOT NEUTRAL. `ITT tends to make the two treatments look similar, whereas the PP removes patients who do not complete treatment and is more able to reflect treatment differences`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t11" type="mechanisms" ana="#mechanisms[5]" resp="#tagger" cert="0.95">
        <label>THE MODIFIED VARIANT HAS NO STABLE DEFINITION AT ALL - `the definition given to the modified ITT (mITT) in randomized controlled trial has been found to be irregular and arbitrary because there is a lack of consistent guidelines for its application. The mITT analysis allows a subjective approach in entry criteria`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t12" type="mechanisms" ana="#mechanisms[6]" resp="#tagger" cert="0.95">
        <label>and it is not one population but many: `multiple mITT populations can be defined for a single study such as clinical mITT and microbiological mITT`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t13" type="mechanisms" ana="#mechanisms[7]" resp="#tagger" cert="0.95">
        <label>THE SAME OBJECT CARRIES A THIRD NAME FROM A THIRD AUTHORITY - ICH E9 `uses the term FULL ANALYSIS SET to describe the analysis set which is as complete as possible and as close as possible to the ITT ideal`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t14" type="limitations" ana="#limitations[0]" resp="#tagger" cert="0.95">
        <label>The guidelines do not agree about where the principle applies. `Whereas the importance of the ITT population analysis in superiority designs has been well accepted, however there is no consensus about its role in non-inferiority trials`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t15" type="limitations" ana="#limitations[1]" resp="#tagger" cert="0.95">
        <label>and the proposed resolution is to require both and hope they agree - `noninferiority should be concluded only if both ITT and PP analyses permit that` - which is a procedure rather than a principle, and the paper notes the conservative effect of PP on such trials `has not been thoroughly explored`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t16" type="limitations" ana="#limitations[2]" resp="#tagger" cert="0.85">
        <label>the remedy offered for the missing data ITT cannot ignore is itself contested - last observation carried forward, `whereby the LAST AVAILABLE MEASUREMENT for each individual at the time point prior to withdrawal IS RETAINED in the analysis`, presented here without its known bias</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t17" type="limitations" ana="#limitations[3]" resp="#tagger" cert="0.85">
        <label>This is a narrative review for beginners, not a systematic one. No search strategy, no inclusion criteria and no synthesis are reported; the claims about what the literature finds - including the central one about mITT - are carried by citation</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t18" type="limitations" ana="#limitations[4]" resp="#tagger" cert="0.95">
        <label>and the practical advice at the end withdraws the problem rather than solving it: `Anyone who follows these principles intelligently and has a vision to minimize bias should not worry further about &#x27;INTENTION TO TREAT&#x27;`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t19" type="transfers" ana="#transfers[0]" resp="#tagger" cert="0.95">
        <label>intention-to-treat is a statistical concept imported into the conduct and reporting of randomized controlled trials to handle noncompliance and missing outcomes</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t20" type="transfers" ana="#transfers[1]" resp="#tagger" cert="0.95">
        <label>the analysis set is defined by the randomized assignment rather than by the treatment actually received, which is what preserves the randomization</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t21" type="controls" ana="#controls[0]" resp="#tagger" cert="0.95">
        <label>randomisation itself - allocating subjects to arms after eligibility is assessed but before the intervention is given</label>
        <note>eliminates: systematic difference between the groups at baseline; ITT exists to protect this and per-protocol analysis is what spends it · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t22" type="controls" ana="#controls[1]" resp="#tagger" cert="0.95">
        <label>requiring full reporting of every deviation from random allocation and every missing response, as CONSORT does</label>
        <note>eliminates: an ITT label attached to an analysis whose exclusions the reader cannot see; the guideline makes the departures visible rather than forbidding them · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t23" type="controls" ana="#controls[2]" resp="#tagger" cert="0.95">
        <label>requiring the ITT and per-protocol analyses to agree before a non-inferiority claim is made</label>
        <note>eliminates: a conclusion that depends on which population was chosen - the two are known to fail in opposite directions, so agreement between them is informative · outcome: partial</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t24" type="concepts" ana="#concepts[0]" resp="#paper" cert="0.95">
        <label>intention-to-treat</label>
        <term>intention-to-treat</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t25" type="concepts" ana="#concepts[1]" resp="#paper" cert="0.95">
        <label>ITT analysis</label>
        <term>ITT analysis</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t26" type="concepts" ana="#concepts[2]" resp="#paper" cert="0.95">
        <label>per-protocol</label>
        <term>per-protocol</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t27" type="concepts" ana="#concepts[3]" resp="#paper" cert="0.95">
        <label>modified ITT</label>
        <term>modified ITT</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t28" type="concepts" ana="#concepts[4]" resp="#paper" cert="0.95">
        <label>full analysis set</label>
        <term>full analysis set</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t29" type="concepts" ana="#concepts[5]" resp="#paper" cert="0.95">
        <label>noncompliance</label>
        <term>noncompliance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t30" type="concepts" ana="#concepts[6]" resp="#paper" cert="0.95">
        <label>prognostic balance</label>
        <term>prognostic balance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t31" type="concepts" ana="#concepts[7]" resp="#paper" cert="0.95">
        <label>type II error</label>
        <term>type II error</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t32" type="concepts" ana="#concepts[8]" resp="#paper" cert="0.95">
        <label>sample size</label>
        <term>sample size</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t33" type="concepts" ana="#concepts[9]" resp="#paper" cert="0.95">
        <label>last observation carried forward</label>
        <term>last observation carried forward</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t34" type="concepts" ana="#concepts[10]" resp="#paper" cert="0.95">
        <label>noninferiority</label>
        <term>noninferiority</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t35" type="concepts" ana="#concepts[11]" resp="#paper" cert="0.95">
        <label>superiority trial</label>
        <term>superiority trial</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t36" type="concepts" ana="#concepts[12]" resp="#paper" cert="0.95">
        <label>heterogeneity</label>
        <term>heterogeneity</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t37" type="senses" ana="#senses[0]" resp="#tagger" cert="0.95">
        <label>`intention-to-treat` (Fisher et al. 1990) - all randomised patients in their assigned groups, `regardless of their adherence with the entry criteria, regardless of the treatment they actually received, and regardless of subsequent withdrawal`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t38" type="senses" ana="#senses[1]" resp="#tagger" cert="0.95">
        <label>`intention-to-treat` (the slogan) - `once randomized, always analyzed`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t39" type="senses" ana="#senses[2]" resp="#tagger" cert="0.95">
        <label>`full analysis set` (ICH E9) - the analysis set `as complete as possible and as close as possible to the ITT ideal` - the same object under a third name</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t40" type="senses" ana="#senses[3]" resp="#tagger" cert="0.95">
        <label>`modified ITT` - a subset with exclusions `in a justified way`, whose definition the literature finds `irregular and arbitrary`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t41" type="senses" ana="#senses[4]" resp="#tagger" cert="0.95">
        <label>`ITT` as a whole-trial strategy - `better regarded as a complete trial strategy for design, conduct and analysis rather than as an approach to analysis alone`</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t42" type="claim_relations" ana="#claim_relations[0]" resp="#tagger" cert="0.95">
        <label>critiques → the modified ITT population as used in randomised trials, whose definition the paper reports as irregular, arbitrary and lacking consistent guidelines</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t43" type="claim_relations" ana="#claim_relations[1]" resp="#tagger" cert="0.95">
        <label>supports → the CONSORT requirement that participants be analysed by the intention-to-treat principle and that deviations be fully reported</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t44" type="claim_relations" ana="#claim_relations[2]" resp="#tagger" cert="0.95">
        <label>concedes → that ITT dilutes the treatment effect and is more susceptible to type II error - the arguments against it &#x27;appear valid&#x27;</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t45" type="concept_edges" ana="#concept_edges[0]" resp="#tagger" cert="0.95">
        <label>ITT analysis —distinct-from→ per-protocol</label>
        <term>ITT analysis</term>
        <term>per-protocol</term>
        <note>the relation itself is separately evidenced · strength of the relation: 0.95 · note: &#x27;ITT tends to…&#x27; Not two views of one number - two numbers, and the analyst picks which before seeing either. · the relation stated: ITT keeps the noncompliers and dilutes the difference; per-protocol removes them and shows it - so the choice of population moves the answer, in a direction that is known in advance</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t46" type="concept_edges" ana="#concept_edges[1]" resp="#tagger" cert="0.95">
        <label>superiority trial —distinct-from→ noninferiority</label>
        <term>superiority trial</term>
        <term>noninferiority</term>
        <note>the relation itself is separately evidenced · strength of the relation: 0.95 · note: &#x27;WHEREAS the importance…&#x27; The same method, the same population, and its authority is a property of the question being asked - which is why &#x27;use ITT&#x27; is not an instruction. · the relation stated: ITT&#x27;s standing depends on what the trial is trying to show: settled as primary in a superiority design, unsettled in a non-inferiority one
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but the span writes &#x27;non-inferiority&#x27;, and the ITT role differs between the two designs; distinct-from is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t47" type="content_tags" ana="#content_tags.findings[0]" resp="#tagger" cert="0.95">
        <label>THE DEFINITION IS A TRIPLE `regardless of` - all randomised patients in their assigned groups `regardless of their adherence with the entry criteria, regardless of the treatment they actually received, and regardless of subsequent withdrawal`</label>
        <term>THE DEFINITION IS A TRIPLE `regardless of` - all randomised patients in their assigned groups `regardless of their adherence with the entry criteria, regardless of the treatment they actually received, and regardless of subsequent withdrawal`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t48" type="content_tags" ana="#content_tags.findings[1]" resp="#tagger" cert="0.95">
        <label>AND IT HAS A SLOGAN THAT IS SHORTER THAN THE DEFINITION - ITT analysis `is usually described as once randomized, always analyzed`</label>
        <term>AND IT HAS A SLOGAN THAT IS SHORTER THAN THE DEFINITION - ITT analysis `is usually described as once randomized, always analyzed`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t49" type="content_tags" ana="#content_tags.findings[2]" resp="#tagger" cert="0.95">
        <label>THE MODIFIED VARIANT&#x27;S DEFINITION IS IRREGULAR AND ARBITRARY, AND THE PAPER SAYS SO - `there is a lack of consistent guidelines for its application. The mITT analysis allows a subjective approach in entry criteria, which may lead to confusion, inaccurate results and bias`</label>
        <term>THE MODIFIED VARIANT&#x27;S DEFINITION IS IRREGULAR AND ARBITRARY, AND THE PAPER SAYS SO - `there is a lack of consistent guidelines for its application. The mITT analysis allows a subjective approach in entry criteria, which may lead to confusion, inaccurate results and bias`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t50" type="content_tags" ana="#content_tags.findings[3]" resp="#tagger" cert="0.95">
        <label>AND ONE STUDY CAN HOLD SEVERAL OF THEM - `multiple mITT populations can be defined for a single study such as clinical mITT and microbiological mITT`</label>
        <term>AND ONE STUDY CAN HOLD SEVERAL OF THEM - `multiple mITT populations can be defined for a single study such as clinical mITT and microbiological mITT`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t51" type="content_tags" ana="#content_tags.findings[4]" resp="#tagger" cert="0.95">
        <label>ICH E9 calls it the full analysis set: as complete as possible and as close as possible to the ITT ideal</label>
        <term>ICH E9 calls it the full analysis set: as complete as possible and as close as possible to the ITT ideal</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t52" type="content_tags" ana="#content_tags.findings[5]" resp="#tagger" cert="0.95">
        <label>ITT tends to make treatments look similar, while per-protocol analysis better reflects treatment differences</label>
        <term>ITT tends to make treatments look similar, while per-protocol analysis better reflects treatment differences</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t53" type="content_tags" ana="#content_tags.findings[6]" resp="#tagger" cert="0.95">
        <label>ITS AUTHORITY DEPENDS ON THE QUESTION - settled as primary in superiority designs, and `there is no consensus about its role in non-inferiority trials`</label>
        <term>ITS AUTHORITY DEPENDS ON THE QUESTION - settled as primary in superiority designs, and `there is no consensus about its role in non-inferiority trials`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t54" type="content_tags" ana="#content_tags.definitions[0]" resp="#tagger" cert="0.95">
        <label>ITT analysis</label>
        <term>ITT analysis</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t55" type="content_tags" ana="#content_tags.definitions[1]" resp="#tagger" cert="0.95">
        <label>full analysis set</label>
        <term>full analysis set</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t56" type="content_tags" ana="#content_tags.definitions[2]" resp="#tagger" cert="0.95">
        <label>modified ITT</label>
        <term>modified ITT</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t57" type="content_tags" ana="#content_tags.definitions[3]" resp="#tagger" cert="0.95">
        <label>last observation carried forward</label>
        <term>last observation carried forward</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t58" type="content_tags" ana="#content_tags.quantities[0]" resp="#tagger" cert="0.95">
        <label>complications ITT exists to absorb</label>
        <term>complications ITT exists to absorb</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t59" type="content_tags" ana="#content_tags.statistics[0]" resp="#tagger" cert="0.95">
        <label>ITT `gives an unbiased estimate of treatment effect` and its estimate `is generally CONSERVATIVE because of DILUTION due to noncompliance`. Both sentences are true and they describe one mechanism - keeping the noncompliers is what preserves the randomisation and what shrinks the difference. A reader who quotes either alone has quoted half of it.</label>
        <term>a bias and a power loss that are the same property seen twice</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t60" type="content_tags" ana="#content_tags.variables[0]" resp="#tagger" cert="0.95">
        <label>analysis population</label>
        <term>analysis population</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
    </spanGrp>
  </standOff>
  <text>
    <body>
      <p><note type="rights">The full text of this article is not redistributable, so it is
      not included here. The evidence sentences are withheld with it; the tag layer and its
      grounding status remain. The article itself is at https://doi.org/10.4103/2229-3485.83221.</note></p>
    </body>
  </text>
</TEI>
